
Genentech, a member of Roche (RHHBY), announced that the FDA has approved Wilserdly in combination with everolimus for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RHHVF | Roche Holding AG | 483.84 | 145.32 | 42.93% |
| Name | Price | % Change | |
|---|---|---|---|
| $483.84 | +42.93% |

Genentech, a member of Roche (RHHBY), announced that the FDA has approved Wilserdly in combination with everolimus for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor

Roche (RHHBY) announced that the FDA has granted De Novo authorization for the cobas pro i 601 platform with the Ionify Gabapentin assay, components of its cobas Mass Spec solution.

Genentech, a member of Roche (RHHBY), announced that the FDA has approved Gazyva for the treatment of adult patients with primary membranous nephropathy at risk of disease progression, to induce

Roche (RHHBY) announced that the European Medicines Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, has recommended the approval of Gazyva/Gazyvaro as an add-on therapy for the treatment

Citi raised the firm’s price target on Roche (RHHBY) to CHF 440 from CHF 400 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate

Roche (RHHBY) announced the U.S. FDA 510(k) clearance of the cobas eplex respiratory pathogen panel 3. Designed for the automated cobas eplex system, this flexible syndromic test offers up to

UBS analyst Matthew Weston downgraded Roche (RHHBY) to Neutral from Buy with a price target of CHF 420, up from CHF 376. The firm cites valuation following the stock’s recent

Roche (RHHBY) announced that it has received the CE Mark for its cobas smart e immunoanalyser, a compact, standalone platform engineered to deliver reliable testing with a planned menu of

Get caught up quickly on the top news from the weekend this five Top Five list. Volkswagen’s (VWAGY) Audi announced plans to establish its first U.S. production site in Georgia.

Genentech, a member of the Roche (RHHBY) Group, announced results from the Phase III Krascendo 1 study, which demonstrated the superior efficacy of investigational divarasib, a next-generation KRAS G12C inhibitor,
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 9, 2026 | ||||
| hold | Reiterated | Nov 4, 2026 | ||||
| hold | Downgraded | Nov 2, 2026 | ||||
| buy | Reiterated | Oct 28, 2026 | ||||
| buy | Reiterated | Oct 27, 2026 | ||||
| hold | Reiterated | Oct 26, 2026 | ||||
| sell | Reiterated | Oct 23, 2026 | ||||
| hold | Reiterated | Oct 23, 2026 | ||||
| buy | Upgraded | Oct 20, 2026 | ||||
| buy | Reiterated | Oct 6, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Jan 28, 2027Before Open | $384.64B | $11.75 | $20.19B | 0.36 | 26.35 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.